adeno-associated virus (AAV) vector gene delivery is another option that might be explored for long-term antibody persistence (Deal and Balazs, 2015) . Finally, though both classes of bispecific antibodies might prove powerful in preventing infection, their use for treatment faces the daunting challenge of impeding escape. All known bNAbs have associated viral resistance mutations. As with highly active antiretroviral drugs, potent and sustained control of the virus may require a combination of bNAbs that simultaneously target multiple sites of action, in this case different epitopes. In vitro predictions of the best existing three and four bNAb combinations suggest limitations in simultaneously targeting more than two epitopes on a majority of viruses (Wagh et al., 2016) . Combinations of synergistic bispecific bNAbs might afford advantages to overcome these limitations. The two lead candidates described above are interesting examples that together encompass four non-overlapping epitopes on gp120, gp41, and cell receptor molecules that would not be expected to exhibit crosscompetition.
Only a small number of bNAbs were known prior to 2009: these early bNAbs provided hope that such antibodies could be elicited by vaccination. They also served as a blueprint for immunogen design. As technologies improved and a new generation of bNAbs with superior neutralization potency and breadth was discovered, interest grew in the potential use of passive bNAbs for HIV prevention and treatment. The outstanding activity of the new synergistic bispecific bNAbs, together with early indications of favorable manufacturability and pharmacokinetic properties, brings us closer to achieving this goal.
The notion that the colon's deep crypt pockets provide a protected location that shields stem cells from potentially toxic substances is widely accepted. In this issue of Cell, Kaiko et al. reveal how a metabolite abundantly produced by the gut microbiota can inhibit stem cell proliferation but is blocked from doing so by crypt architecture.
The colonic epithelium is organized as a flat surface epithelium with highly repetitive invaginations known as crypts of Lieberkü hn. Actively proliferating colonic stem cells are located at the very bottom of these crypts and fuel the self-renewal of the epithelium. Fully differentiated colonocytes cover the flat surface of the colon and are continuously replaced by new generations of cells that exit the crypt pockets. Despite detailed knowledge about developmental signaling pathways that regulate stem cell positioning, function, and number (Barker, 2014) and the role of the colonic epithelium in maintaining a barrier against potentially harmful microorganisms and toxins (Garrett et al., 2010) , mechanistic insights into the complex interactions between gut microbes and colonic tissue has so far lacked behind.
In this issue of Cell, Kaiko et al., (2016) investigate how primary colon organoids that are enriched for highly proliferative stem/progenitor cells are influenced by a previously identified set of metabolites produced by the commensal gut microbiota and that are commonly found in the colonic lumen of mice (Matsumoto et al., 2012) . Butyrate-a product of dietary fiber fermentation-had the most significant negative effect at physiological concentrations. Surprisingly however, the authors found that altering the butyrate concentrations during homeostatic conditions in the mouse colon did not affect proliferation of the stem/progenitor cells. Instead, they demonstrated that the architecture of the colon, with the stem/progenitor cells protectively nestled at the bottom of crypt pockets, prevents them from exposure to the butyrate in the lumen. Damage to the surface epithelium that disrupted crypt architecture and exposed the stem cell niches to butyrate inhibited the proliferative activity of the stem/progenitor cells. In contrast, elimination of butyrate-producing bacteria with antibiotics enhanced healing of wounds in the colonic epithelium.
The authors investigate how the crypt structure shields the stem cells from butyrate and provide evidence that the spatial dimensions themselves create a butyrate gradient by diffusion. Perhaps even more importantly, they show that luminal butyrate is used as an energy source by colonocytes that reside outside the crypt, suggesting that butyrate is consumed at the ''gates'' to the stem cell niche (Figure 1) . Indeed, impaired metabolism of butyrate by these colonocytes decreased proliferation in the crypt and also dramatically reduced regenerative capacity after epithelial injury.
Turning their attention to how butyrate impacts stem cell growth, the authors show that butyrate acts as an HDAC inhibitor, thereby facilitating increased binding of the negative cell-cycle regulator Foxo3 to promoter regions of key cell-cycle genes. Most convincingly, genetic deletion of Foxo3 reduced the sensitivity of the colonic stem cell niche to luminal butyrate levels.
The manuscript by Kaiko et al., (2016) provides valuable insights into how epithelial architecture contributes to optimizing the symbiosis of the host gut and the resident microbiota. The strong interdependencies between microbiota and animals fuelled the development of a theory that microorganisms and their products have played important roles in the evolution of their hosts (McFall-Ngai et al., 2013) . However, what the exact impact of the microbiome has been on the evolution of crypt architecture remains a matter of speculation. For instance, the stomach and duodenum utilize similar self-renewing strategies as the colon by harboring their stem cells at the base of crypt pockets, but in comparison to the colon, the microbiota density is not nearly as great. One might hypothesize though, in light of the new data on crypts as a butyrate shield, that a crypt structure may also provide protection against a much wider range of luminal substances such as those derived from food or pathogens.
In addition to a protective function against either luminal products or physical injury to the surface epithelium, we have suggested that compartmentalization of stem cell populations in repetitive small niches (i.e., crypts) also forms a natural hurdle to minimize the expansion of pro-tumorigenic mutant cell clones, thereby reducing the risk of developing cancer (Vermeulen and Snippert, 2014) . Ultimately, during evolution, multiple types of selection often act in concert and it is highly conceivable that many mechanisms have coincided to shape the structure of the intestinal epithelium.
Pioneering work on decreased epithelial turnover rates and crypt sizes in germ-free rats provided early evidence for the trophic effect of bacteria-produced short-chain fatty acids such as butyrate on colonic epithelium (Alam et al., 1994; Frankel et al., 1994) . The current study by Kaiko et al., (2016) provides detailed insight into the actions of bacteria-produced butyrate on epithelial homeostasis of the gut, and the role of its architecture therein. While Kaiko and colleagues confirmed butyrate as a positive effector, i.e., an energy source, for the differentiated colonocytes outside the crypt, they showed that it had negative effects on stem/progenitor cell proliferation in the crypt in vivo. This difference highlights how distinct cell populations within the epithelium tolerate the microbiota and its products in their own unique manner, underscoring the fact that the symbiotic equilibrium between the colonic epithelium and its microbiota is not a simple two-way interaction. Of course, the actions of butyrate only represent one thread within a much more complex network of intestinal microorganisms, the immune system, and the intestinal epithelium that is far from a homogenous population of cells. Nevertheless, this study makes an important contribution toward awareness about the complexity of the symbiotic nature of the host-microbial relationship. The stem cell niche resides at the very bottom of the crypts (colonic stem cells in green). Bacteria (rod shapes) reside in the lumen and produce extensive amounts of the short-chain fatty acid butyrate (chemical structures). Due to butyrate metabolism by colonocytes (energy source) and limited diffusion toward the stem cell niche due to the crypt structure, there is a natural gradient of butyrate along the cryptsurface axis. As a result, exposure of butyrate to colonic stem cells is limited, thereby preventing its negative effects on the proliferative activity of stem/progenitor cells.
The sense of smell is mediated by GPCRs in the odorant receptor (OR) family. Greer et al. report a new family of odor detectors, MS4As, that have similar cellular localization and chemodetection ability as ORs but are not GPCRs and follow a strikingly different logic of odor coding at the periphery.
The ability of animals to sense their environment is crucial for their survival and well-being. In vision, the photon is the sole unit of information, so just a few primary receptors can detect and decode a vast amount of information. The problem is different for olfaction because odor language is diverse, with a spectrum of organic chemical elements that produce a nearly infinite variety of volatile odor molecules. What is the repertoire of receptors needed to detect the chemical environment? In this issue of Cell, Greer et al. report the discovery of a new and unforeseen family of mammalian odor receptors that recasts our understanding of how olfaction works (Greer et al., 2016) .
How do sensory neurons account for the immense range of odor discrimination and perception? In 1991, Axel and Buck found that, unlike vision, the logic of the olfactory system is more analogous to the immune system (Buck and Axel, 1991; Malnic et al., 1999) , with hundreds of variants of a specialized family of G-protein-coupled odorant receptors (GPCR ORs). Each is tuned to a specific piece of an odor molecule, and each sensory neuron expresses just one of the OR variants ( Figures 1A and 1B) . Individual odors activate different combinations of sensory neurons, whose combined activity tells the brain which molecules are present in the environment (Touhara and Vosshall, 2009) . Nobel awarded, case solved, right?
Yet since the discovery of the OR genes, a comprehensive picture of how mammals detect and process odors has remained elusive, given the hundreds of known receptors and the perhaps limitless undefined odor space. That means the field will not know when it has accounted for all of the receptors that sense odor. Indeed, a small family of GPCRs unrelated to ORs, trace amine-associated receptors (TAARs), were also found to be olfactory sensory receptors ( Figure 1C ) (Liberles and Buck, 2006) , showing that odorant detection is not confined to a single molecular family.
Perhaps multiple receptor families exist because there are two different functional classes of odors. For the first class, experience is necessary to identify and assign value to the odors. You smell a pizza, you eat a pizza-the meaning of the association, good or bad, is learned and can change if the next experience with that odor has a different outcome. The second class is specialized and activates neural circuits ''pre-programmed'' with meaning, as is the case for pheromones. The sniff of specialized odors has a high probability to generate the same behavior across individuals, with limited flexibility (Stowers and Logan, 2010) . While some specialized odors are detected by an olfactory subsystem (the vomeronasal organ), few specialized receptors are known (Liberles, 2014) . The advent of deep sequencing promised to identify novel chemodetectors, but nothing new has been reported. Perhaps this is because the assumptions were wrong. It has been presumed that one should be looking for new families of GPCRs with a single receptor type expressed per sensory neuron.
Greer and colleagues put aside canonical assumptions and used deep sequencing and nanostring technologies and discovered a new family of receptors expressed by olfactory sensory neurons, the MS4As ( Figure 1D ). Members of this family were previously studied in the context of calcium signaling in the immune system, although their ligands were unknown (Eon Kuek et al., 2016) . Both in vivo and in vitro analyses clearly demonstrate that the MS4As fulfill the expected criteria of odorant receptors. MS4As are localized at neural termini
